Skip to main content
    Health Library

    Weight management · 5 min read · Evidence-informed guide

    GLP-1 Safety Warnings: Important Questions Before Treatment

    GLP-1-based medicines have important contraindications and warnings. For example, Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2; product-specific risks and interactions must be reviewed before prescribing.

    Key answer

    The short version

    GLP-1-based medicines have important contraindications and warnings. For example, Wegovy is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2; product-specific risks and interactions must be reviewed before prescribing.

    Read the product label with a clinician

    Labels address pancreatitis, gallbladder disease, dehydration-related kidney injury, severe gastrointestinal reactions, hypoglycemia with certain diabetes medicines, allergic reactions, and other product-specific concerns.

    Procedures and other medicines matter

    Tell every clinician and anesthesia team about GLP-1 treatment before a procedure. Delayed gastric emptying and interactions with other medicines can affect planning and monitoring.

    Pregnancy deserves advance planning

    Discuss pregnancy, breastfeeding, and planned pregnancy before treatment or as soon as plans change. Follow the approved product label and individualized guidance from the prescribing clinician.

    Clinical perspective

    How to think about this

    Prescription weight management is longitudinal medical care, not a consumer transaction. A sound plan weighs approved use, safety, nutrition, access, follow-up, and the patient’s own goals; it should never reduce a complex health decision to a promised outcome or a single number on a scale.

    Questions worth bringing to a visit

    • What FDA-approved option, if any, fits my clinical situation?
    • What safety monitoring and follow-up would I need?
    • How will we assess benefit, tolerability, and access over time?

    Continue exploring

    Related patient questions

    GLP-1 Weight-Loss Medicines: Questions to AskRead article Semaglutide vs. Tirzepatide: What Is the Difference?Read article Who May Qualify for GLP-1 Weight-Loss Medicine?Read article

    Sources

    1. 1. FDA, Wegovy Prescribing Information

      Contraindications, warnings, procedure considerations, and reproductive guidance.

    2. 2. FDA, Update on GLP-1 medicines and suicidal thoughts or actions

      FDA safety-communication context.